Target intelligence / Profile preview

MicroRNA 3180-1 (MIR3180-1)

Target
MIR3180-1
Molecular classification
MicroRNA, Short non-coding RNA
01

Overview

MicroRNA 3180-1 (MIR3180-1) is a member of the microRNA family of small (20–24 nucleotide) non-coding RNAs that mediate post-transcriptional regulation of gene expression, primarily by binding to complementary sequences on target mRNAs, resulting in their degradation or translational repression. The stem-loop precursor of MIR3180-1 is processed by Drosha and Dicer enzymes, and the mature microRNA is incorporated into RISC to exert its effects. MIR3180-1 is cataloged in multiple genomic resources and is associated with the regulation of actinomycosis-related genes, with possible (but not directly evidenced) roles in neurodegenerative processes such as Alzheimer's disease through mechanisms common to the microRNA class. As with all microRNAs, MIR3180-1 is not a receptor, enzyme, or transporter and does not serve as a direct therapeutic target, though alterations in its expression and function may influence disease biology[3][4][6].

Other names
hsa-mir-3180-1MIR3180-1miRNA-3180-1HGNC:38382NCBI Gene:100422870Ensembl:ENSG00000265537
02

Mechanism of action

null.

03

Biological functions

Post-transcriptional gene regulation
04

Disease associations

Actinomycosis

Beyond the preview

Go deeper on MicroRNA 3180-1 (MIR3180-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3180-1 (MIR3180-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call